Tuesday, November 18, 2008
Developments in Terahertz Imaging
and its
Applications to Industry
Presented by
Philip F Taday, Ph.D.
Teraview Limited
The exceptional properties of
terahertz radiation, such as ability to penetrate most non-polar
materials that can be opaque for visible light or low contrast
for x-rays and very importantly, low photon non-ionizing
energies, make this radiation very attractive tool for aiding
understanding of materials and products.
The coating of tablets that are of great importance to both the
consumer and the pharmaceutical manufacturer. By controlling the
release of the active pharmaceutical ingredient (API) tablet
coatings ensure bioavailability, minimize harmful effects and
the waste of the drug by delivering it at the specific site and
at the optimum level. These functions may be compromised if a
coating is non-uniform or has defects. Until recently, the
analysis of coating thickness relied on indirect techniques and
it was usually determined by the weight gain of the coated
tablet compared to the uncoated tablet core. Near-infrared and
Raman spectroscopic and imaging techniques developed in recent
years to yield information about the quality and integrity of
the coatings are usually restricted to the outer surface of the
tablet. In order to test the coating for uniformity or to
analyze buried structures or even multiple layers within the
tablet, the tablet has to be cut and spectroscopic images to be
acquired for each layer. However, in contrast to the
near-infrared and mid-infrared regions of the electromagnetic
spectrum, many of the excipients used for coating solid dosage
forms are transparent or semi-transparent to terahertz
radiation. Moreover, terahertz radiation can easily penetrate
commonly used coating polymers. This in turn means that, unlike
aforementioned techniques, terahertz pulsed imaging
non-destructively provides spatially resolved information from
below the surface of the tablet. Consequently, terahertz
measurements are arguably more suited to monitor key quality
attributes of the pharmaceutical solid dosage forms during the
manufacturing.
Register